Evidence map›Paper›PMID 42621333›Full record

ArticleCurrent research in food science2026

Peptidomic evidence for pH-stat flavourzyme-mediated debittering of Alcalase-derived rice protein hydrolysates.

Pei-Yu Wu, Yu-Shun Lin, Mei-Ling Li, Yun-Hsuan Chien, Shang-Ming Huang, Kuo-Chiang Hsu

Abstract read
In one paragraph

Article in Current research in food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pei-Yu WuDepartment of Nutrition, China Medical University, No.100, Sec.1, Jingmao Rd., Beitun Dist., Taichung City, 406040, Taiwan.
Yu-Shun LinDepartment of Nutrition, China Medical University, No.100, Sec.1, Jingmao Rd., Beitun Dist., Taichung City, 406040, Taiwan.
Mei-Ling LiDepartment of Nutrition, China Medical University, No.100, Sec.1, Jingmao Rd., Beitun Dist., Taichung City, 406040, Taiwan.
Yun-Hsuan ChienDepartment of Nutrition, China Medical University, No.100, Sec.1, Jingmao Rd., Beitun Dist., Taichung City, 406040, Taiwan.
Shang-Ming HuangDepartment of Nutrition, China Medical University, No.100, Sec.1, Jingmao Rd., Beitun Dist., Taichung City, 406040, Taiwan.
Kuo-Chiang HsuDepartment of Nutrition, China Medical University, No.100, Sec.1, Jingmao Rd., Beitun Dist., Taichung City, 406040, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavourzyme-assisted two-stage hydrolysis is a recognized debittering strategy for protein hydrolysates, yet peptidomic-level evidence for the underlying mechanism-particularly the role of pH control mode-remains limited. This study compared pH-stat and free-fall pH Flavourzyme treatments (3 and 4 h) of an Alcalase-derived rice protein hydrolysate (A6; degree of hydrolysis by the o-phthalaldehyde method [DH-OPA] 24.69%) using nanoLC-ESI-Q-TOF de novo sequencing to characterize peptide-profile changes associated with bitterness reduction. Formal sensory evaluation (15 trained panelists, paired comparison with Bonferroni correction for 10 comparisons) of the ultrafiltered (<2500 Da) fractions placed A6-s3 (pH-stat, 3 h) at the least-bitter end of the ranking, although it did not differ significantly from A6-s4 after multiplicity correction. The apparent ranking differed from that observed in the preliminary evaluation of unfiltered hydrolysates, which used a smaller panel and a different sensory design. De novo sequencing identified 963-1226 peptides per hydrolysate. A6-s3 exhibited the lowest mean Q value (1430 cal mol

Indexed as

BitternessDebitteringEnzymatic hydrolysisFlavourzymePeptide profilePeptidomicspH control modeQ valueRice protein

Identifiers

PMID42621333
PMCPMC13487615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.